Coherent receives ISO 13485 certification for Goettingen facility

Article

Coherent Inc. has recently expanded its ISO 13485 certification in Europe to include the Excimer laser design and manufacturing facility located in Goettingen, Germany.

Santa Clara, Calif., Sept. 11, 2009 — Coherent Inc. (Santa Clara, CA) (Nasdaq: COHR) has recently expanded its ISO 13485 certification in Europe to include the Excimer laser design and manufacturing facility located in Goettingen, Germany. ISO 13485 is an international standard that defines the requirements of comprehensive quality management systems for the design, development, production, customer service and assembly of medical devices. ISO 13485 also specifies protocols for adherence to customer requirements and product improvement within the European regulatory framework for medical devices.

“Achieving ISO 13485 certification benefits all customers who integrate Coherent’s excimer laser products into their surgical systems for eye correction,” notes Heiner Felder, Quality Manager for Medical Products. “The Goettingen certification provides Coherent’s medical customer with expanded capabilities and supplements the existing ISO 13485 certification of the Munich facility. We have now successfully integrated and synchronized all our quality systems for excimer lasers within Coherent.”

Founded in 1966, Coherent, Inc. is a Russell 2000 Index company and a world leader in providing laser-based solutions to the commercial and scientific research markets. Please direct any questions to Heiner Felder, Quality Manager for Medical Products at +49 89 5892746 10. For more information about Coherent, including product and financial updates, visit our website at:
www.coherent.com/excimer

Contact details
Petra Wallenta, PR Manager Europe
+49 89 5892746 25
petra.wallenta@coherent.com

Heiner Felder
+49 89 5892746 10
heiner.felder@coherent.com

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.